Each year increasing numbers of foreign life sciences/biotech companies seek venture capital in the US. Many of these foreign companies have never raised US venture capital and have limited knowledge of the process. This panel will focus on providing valuable insight on identifying the right venture capitalists for your company based on technology, deal size, and investment stage, securing a hearing, presenting and negotiating the investment successfully. In a lively discussion, seasoned venture capitalists will provide foreign companies with a road map to accessing US venture capital.

• Educate foreign life sciences/biotech companies on obtaining US venture capital and pros/cons of taking venture capital in contrast to alternative forms of capital
• Help foreign companies understand the value-add of US venture capital
• Guide foreign companies in working with venture capitalists on their Boards and the venture capitalists' ultimate exit/liquidity goals through IP or M&A